trending Market Intelligence /marketintelligence/en/news-insights/trending/7nh_cvqffbj53mmibc0m4w2 content esgSubNav
In This List

Veracyte nets $55.1M from common stock offering

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Veracyte nets $55.1M from common stock offering

Veracyte, Inc. closed its public offering of common stock with about $55.1 million in net proceeds.

The South San Francisco, Calif.-based molecular diagnostics company offered 5,750,000 shares at $10.25 apiece, which included 750,000 shares bought by the underwriters after they fully exercised their option to buy additional shares.

Veracyte intends to use the net proceeds for working capital and other general corporate purposes. The company may also use the funds for potential acquisitions.

Leerink Partners and William Blair acted as joint book-running managers, while BTIG served as lead manager for the offering.